Professor Glenda Halliday’s research on Parkinson’s disease (PD) and dementia with Lewy bodies is incorporated into diagnostic research criteria-only Australian on current task force redefining PD diagnosis. In frontotemporal dementia, performed the 1st large-scale clinicopathological and survival analyses, developed a disease severity staging scheme-research also incorporated into diagnostic criteria and international studies identifying novel genes and pathologies. 2006-7 president of Australian Neuroscience Society (ANS), secretary of Asia/Pacific Regional Committee of International Brain Research Organisation (2010-), and on scientific advisory boards for an international and australian research institution. 2011 ANS Nina Kondelos Prize winner for outstanding neuroscience, and NHMRC high achiever.